SCHEDULE 13G

Company

Spyre Therapeutics, Inc.

Filed

October 26, 2020

Accession Number

0000899140-20-000490

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →